Status:
UNKNOWN
A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study)
Lead Sponsor:
Qin Ning
Conditions:
Hepatitis B, Chronic
Eligibility:
All Genders
18-65 years
Brief Summary
This is a prospective, multicentre observational follow-up study of PegIFN treatment unstained response in nucleoside experienced patients with Chronic Hepatitis B.Patients will join this study after ...
Detailed Description
Patients who treated with nucleoside analogs, and previously took part in the OSST,COST,Endeavor, Anchor NPGV studies, were included in the observational study after they finished. The patients entere...
Eligibility Criteria
Inclusion
- Male and female patients from 18 to 65 years of age;
- Have finished the OSST,COST,Endeavor, Anchor,NPGV studies;
- Agree to participate in the study and sign the patient informed consent.
Exclusion
- patients have not participated in the OSST,Cost,Endeavor,Anchor or NPGV study ;
- unable or unwilling to provide informed consent or follow the research requirements
Key Trial Info
Start Date :
February 27 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT03358108
Start Date
February 27 2018
End Date
December 1 2022
Last Update
October 19 2018
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
BeiJing YouAn Hospital, Capital Medical University
Beijing, Beijing Municipality, China
2
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
3
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
4
The First Affiliated Hospital of College of Medicine, Zhejiang University
Zhejiang, Hangzhou, China, Doctor